Pharmaceutical Supply for Osteoporosis Agents

The contract involves the supply of osteoporosis treatments, specifically Denosumab analogs available in both injectable and oral forms, as outlined in the Defense Health Agency's formulary. It is a subcontract opportunity under the NAICS code 325412, which covers pharmaceutical manufacturing. The contract aims to support the Department of Defense by ensuring the availability of these critical medications to address osteoporosis within their healthcare system. The solicitation was posted on June 8, 2026, with a response deadline set for June 29, 2026, at 5:00 PM. The place of performance is designated by the zip code 78230, though no specific city or state is provided. This contract does not indicate any set-aside status, suggesting it is open to eligible suppliers within the pharmaceutical sector. The opportunity reflects the ongoing need for reliable pharmaceutical supply chains to meet medical treatment requirements for service members and beneficiaries under the Defense Health Agency's purview.